Amin Shahrbaf M, Samimi M, Karimi S, Salari M, Ghaffari M, Yazdanbakhsh S, Najafian A, Vosough M, Massood Nabavi S. The first study of real-world efficacy and safety of Natalizumab (Tysabri®) in Iran. Trends Immunother. [Internet]. 2024 Mar. 12 [cited 2025 Apr. 3];8(1). Available from: https://ojs.ukscip.com/index.php/ti/article/view/476